Department of Economics and Business Economics

Determinants of Generic vs. Brand Drug Choice: Evidence from Population-wide Danish Data

Research output: Working paperResearch

Documents

  • Wp13 05

    Submitted manuscript, 793 KB, PDF document

When prescription medications go off patent, vastly cheaper generic drugs usually enters the market. However, the original brand medication often maintains non-negligible market shares. This paper investigates whether demand for branded medications in post-patent markets is patient- or doctor driven. We use population-wide Danish register data including all prescriptions for seven blockbuster drugs from 1998-2008. At the outset, descriptive statistics suggest large variation in drug choice over doctors. Nonetheless, using a two-way fixed effects model we find that the primary determinants of brand drug use are unobserved patient characteristics and price effects, while observed and unobserved doctor characteristics in general explain only 0.7 % of the variation in drug choice. This is suggestive evidence that the doctors in the Danish setting with no incentives to push expensive brand drugs do indeed not do so. Our results also suggest that one should be careful when applying fixed effects in small samples.
Original languageEnglish
Place of publicationAarhus
PublisherInstitut for Økonomi, Aarhus Universitet
Number of pages28
Publication statusPublished - 14 Mar 2013
SeriesEconomics Working Papers
Number2013-05

See relations at Aarhus University Citationformats

Download statistics

No data available

ID: 53280803